License 1 - License 2
Mentions: We found statistically significant increased levels of [-2]proPSA and PHI in patients diagnosed with prostate cancer by prostate biopsy vs. patients with benign prostate hypertrophy ([-2]proPSA median 14 vs. 27 pg/mL, PHI median 35 vs. 77). In the contrary, we did not find any significant difference in tPSA and %freePSA (median tPSA 7.1 vs. 7.7 ng/mL and %freePSA 16 vs.11.4%). According to receiver operating characteristic (ROC) curves is PHI the best parameter for distinguishing benign and malignant prostate tumor (Figure 1).
No MeSH data available.